Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China
· Delayed Price · Currency is CNY 12.42
+0.18 (1.47%)
Mar 10, 2026, 3:04 PM CST
SHE:301211 Market Cap
SHE:301211 has a market cap or net worth of 5.19 billion as of March 10, 2026. Its market cap has decreased by -4.31% in one year.
Market Cap
5.19B
Enterprise Value
3.62B
Revenue
430.77M
Ranking
n/a
PE Ratio
137.18
Stock Price
12.42
Market Cap Chart
Since December 22, 2021, SHE:301211's market cap has decreased from 8.96B to 5.19B, a decrease of -42.09%. That is a compound annual growth rate of -12.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 5.19B | 1.64% |
| Dec 31, 2025 | 5.10B | -16.66% |
| Dec 31, 2024 | 6.12B | -2.25% |
| Dec 29, 2023 | 6.26B | -24.68% |
| Dec 30, 2022 | 8.32B | -7.87% |
| Dec 31, 2021 | 9.03B | 0.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuan Pharmaceutical (Group) | 5.10B |
| Luoxin Pharmaceuticals Group Stock | 5.10B |
| Nanjing Hicin Pharmaceutical | 5.03B |
| Beijing Science Sun Pharmaceutical | 5.21B |
| Zhejiang Yatai Pharmaceutical | 4.98B |
| Ningbo Menovo Pharmaceutical | 4.98B |
| Hunan Fangsheng Pharmaceutical | 5.27B |
| Zhuhai Rundu Pharmaceutical | 5.29B |